[可避免的副作用:10种药物组合需要密切关注]
Fabiano Casso1, Ayoub Larabi2, Virginie Moulin1
1Département de médecine interne, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Revue medicale suisse
|November 20, 2025
概括
本综述强调了10种常见的药物组合,如SSRI-tramadol,这些组合对多种药物的患者构成重大风险. 了解这些药物相互作用可以提高处方安全性和患者护理.
科学领域:
- 内部医学 内部医学
- 临床药理学 临床药理学
- 药物监督 药物监督 药物监督
背景情况:
- 药物相互作用是内部医学中不良事件的常见原因.
- 多种药物治疗增加了潜在有害药物组合的风险.
研究的目的:
- 审查具有显著临床风险的10种常见药物组合.
- 为更安全的处方提供关于管理药物相互作用的指导.
主要方法:
- 关于常见药物相互作用的文献综述.
- 分析机制,临床后果和管理策略.
主要成果:
- 确定了10种高风险药物组合,包括SSRI-特拉马多尔,他类药物-CYP3A4抑制剂,酸盐-PDE5抑制剂和-NSAIDs/利尿剂.
- 详细说明了每个相互作用的药理基础和临床影响.
结论:
- 对于处方者来说,对这些药物相互作用的认识至关重要.
- 实施实际建议可以提高患者的安全性和护理质量.
相关概念视频
Pharmacokinetics: Drug–Drug Interactions
329
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
329
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
189
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
189
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Therapeutic Drug Monitoring: Affecting Factors
183
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
183


